Volume 53, Issue 4, Pages (April 1998)

Slides:

Advertisements

Similar presentations

Management of IgA nephropathy: Evidence-based recommendations

Advertisements

Volume 54, Issue 2, Pages (August 1998)

Volume 55, Issue 2, Pages (February 1999)

Plasma sodium and hypertension

Combination therapy with ACE inhibitors and angiotensin II receptor blockers in chronic renal disease: New therapeutic world beyond blood pressure reduction

Frederik Persson, Peter Rossing Kidney International Supplements

Viper venom for diabetic nephropathy

Francesco Locatelli, Lucia Del Vecchio, Simeone Andrulli, Sara Colzani

Volume 67, Issue 6, Pages (June 2005)

Membranous nephropathy: When and how to treat

Viper venom for diabetic nephropathy

Gudrun Hatlen, Solfrid Romundstad, Stein I. Hallan

Volume 54, Issue 2, Pages (August 1998)

Peter Rossing, Philip Hougaard, Hans-Henrik Parving

G protein β3 subunit C825T polymorphism in primary IgA nephropathy

Volume 53, Issue 4, Pages (April 1998)

‘Progressive diabetic nephropathy. How useful is microalbuminuria

Volume 81, Issue 7, Pages (April 2012)

Audit-based education: a potentially effective program for improving guideline achievement in CKD patients Moniek C.M. de Goeij, Joris I. Rotmans Kidney.

Volume 55, Issue 2, Pages (February 1999)

Volume 57, Pages S32-S37 (April 2000)

Progression of diabetic nephropathy

Volume 54, Issue 4, Pages (October 1998)

Steven J. Rosansky, Richard J. Glassock Kidney International

The epidemiology of chronic kidney disease

Volume 65, Issue 6, Pages (June 2004)

Blood pressure targets in hemodialysis patients

Volume 59, Issue 4, Pages (April 2001)

David M. Charytan, John P. Forman Kidney International

Volume 67, Issue 1, Pages (January 2005)

Progression of diabetic nephropathy: Role of plasma homocysteine and plasminogen activator inhibitor-1 Peter Hovind, MD, Lise Tarnow, MD, Peter Rossing,

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Volume 63, Pages S38-S42 (February 2003)

The future of renoprotection: Frustration and promises

Environmental exposure to lead and progressive diabetic nephropathy in patients with type II diabetes J.-L. Lin, D.-T. Lin-Tan, C.-C. Yu, Y.-J. Li, Y.-Y.

Volume 87, Issue 1, Pages (January 2015)

Volume 53, Issue 4, Pages (April 1998)

The kidney, a cardiovascular risk marker, and a new target for therapy

Volume 67, Issue 4, Pages (April 2005)

Volume 67, Pages S52-S54 (January 2005)

Nephrology Crossword: Glomerulonephritis

Volume 74, Issue 5, Pages (September 2008)

Volume 69, Issue 8, Pages (April 2006)

Volume 60, Issue 1, Pages (July 2001)

Circadian regulation of renal function

Volume 57, Issue 2, Pages (October 2000)

Volume 78, Issue 5, Pages (September 2010)

Carmine Zoccali, Francesca Mallamaci Kidney International

Volume 73, Issue 5, Pages (March 2008)

Organ transplantation goes to the movies

Volume 63, Issue 4, Pages (April 2003)

Glucose transporter (GLUT1) allele (XbaI–) associated with nephropathy in non-insulin- dependent diabetes mellitus Zhi-Hong Liu, Tian-Jun Guan, Zhao-Hong.

Volume 68, Pages S98-S102 (December 2005)

Is it the low-protein diet or simply the salt restriction?

Volume 57, Issue 3, Pages (March 2000)

Volume 64, Issue 4, Pages (October 2003)

Volume 70, Issue 3, Pages (August 2006)

Is complement a target for therapy in renal disease?

Volume 56, Issue 4, Pages (October 1999)

Volume 75, Issue 7, Pages (April 2009)

Volume 68, Issue 3, Pages (September 2005)

Volume 58, Issue 2, Pages (August 2000)

Volume 68, Issue 3, Pages (September 2005)

Gary R. Sirken, Chetan Shah, Rasib Raja Kidney International

Friends, social networks, and progressive chronic kidney disease

Volume 57, Issue 2, Pages (October 2000)

Volume 60, Issue 2, Pages (August 2001)

Volume 79, Issue 10, Pages (May 2011)

Antonio Piccoli, Luana Pillon Kidney International

Presentation transcript:

Volume 53, Issue 4, Pages 1002-1006 (April 1998) Angiotensin converting enzyme gene polymorphism and ACE inhibition in diabetic nephropathy Peter Jacobsen, Kasper Rossing, Peter Rossing, Lise Tarnow, Christine Mallet, Odette Poirier, Francois Cambien, Hans-Henrik Parving Kidney International Volume 53, Issue 4, Pages 1002-1006 (April 1998) DOI: 10.1111/j.1523-1755.1998.00847.x Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 1 Change in Log10 (albuminuria) versus change in mean arterial blood pressure (MABP) revealed the following regression slopes (95% CI): II (..▾..), 0.044 (0.024 to 0.064; R2= 0.65, P = 0.0005); ID (–•–), -0.003 (-0.017 to 0.012; R2= 0.01, P = 0.67); and DD, (—▪—), 0.008 (-0.003 to 0.019; R2= 0.06, P = 0.14). Kidney International 1998 53, 1002-1006DOI: (10.1111/j.1523-1755.1998.00847.x) Copyright © 1998 International Society of Nephrology Terms and Conditions